Des-acyl ghrelin: A metabolically active peptide

Endocrine Development

Volumn 25, Issue , 2013, Pages 112-121

  Delhanty, Patric J ^a   Neggers, Sebastian J ^a   Van Der Lely, Aart J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLATED GHRELIN; DES ACYL GHRELIN; GHRELIN; UNCLASSIFIED DRUG; GHRELIN RECEPTOR; GLUCOSE; OBESTATIN; PEPTIDE DERIVATIVE;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; DIABETIC OBESITY; HUMAN; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; WEIGHT REDUCTION; GLUCOSE BLOOD LEVEL; HORMONAL REGULATION; PROTEIN DEGRADATION;

ACYLATION; ACYLTRANSFERASES; ANIMALS; GHRELIN; HUMANS; RECEPTORS, GHRELIN;

EID: 84925852166     PISSN: 14217082     EISSN: 16622979     Source Type: Book Series    
DOI: 10.1159/000346059     Document Type: Article

References (32)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-660.
2. Gutierrez JA, Solenberg PJ, Perkins DR, Willency JA, Knierman MD, Jin Z, Witcher DR, Luo S, Onyia JE, Hale JE: Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci USA 2008; 105:6320-6325.
3. Yang J, Brown MS, Liang G, Grishin NV, Goldstein JL: Identification of the acyltransferase that oc-tanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 2008; 132:387-396.
4. Kang K, Schmahl J, Lee JM, Garcia K, Patil K, Chen A, Keene M, Murphy A, Sleeman MW: Mouse ghre-lin-O-acyltransferase (GOAT) plays a critical role in bile acid reabsorption. FASEB J 2012; 26:259-271.
5. Broglio F, Gottero C, Prodam F, Gauna C, Muccioli G, Papotti M, Abribat T, van der Lely AJ, Ghigo E: Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. J Clin Endocrinol Metab 2004; 89:3062-3065.
6. Gauna C, Meyler FM, Janssen J, Delhanty PJD, Abribat T, Van Koetsveld P, Hofland LJ, Broglio F, Ghigo E, van der Lely AJ: Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. J Clin Endocrinol Metab 2004; 89:5035-5042.
7. Granata R, Baragli A, Settanni F, Scarlatti F, Ghigo E: Unraveling the role of the ghrelin gene peptides in the endocrine pancreas. J Mol Endocrinol 2010; 45: 107-118.
8. Delhanty PJ, van der Lely AJ: Ghrelin and glucose homeostasis. Peptides 2011; 32:2309-2318.
9. Granata R, Settanni F, Biancone L, Trovato L, Nano R, Bertuzzi F, Destefanis S, Annunziata M, Marti-netti M, Catapano F, Ghe C, Isgaard J, Papotti M, Ghigo E, Muccioli G: Acylated and unacylated ghre-lin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3 ′, 5′-cyclic adenosine monophosphate/protein ki-nase A, extracellular signal-regulated kinase 1/2, and phosphatidylinositol 3-kinase/Akt signaling. Endocrinology 2007; 148:512-529.
10. Gauna C, Delhanty PJ, Hofland LJ, Janssen JA, Bro-glio F, Ross RJ, Ghigo E, van der Lely AJ: Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes. J Clin Endo-crinol Metab 2005; 90:1055-1060.
11. Kumar R, Salehi A, Rehfeld JF, Hoglund P, Lindstrom E, Hakanson R: Proghrelin peptides: Desacyl ghrelin is a powerful inhibitor of acylated ghrelin, likely to impair physiological effects of acyl ghrelin but not of obestatin. A study of pancreatic polypep-tide secretion from mouse islets. Regul Pept 2010; 164:65-70.
12. Asakawa A, Inui A, Fujimiya M, Sakamaki R, Shin-fuku N, Ueta Y, Meguid MM, Kasuga M: Stomach regulates energy balance via acylated ghrelin and de-sacyl ghrelin. Gut 2005; 54:18-24.
13. Inhoff T, Monnikes H, Noetzel S, Stengel A, Goebel M, Dinh QT, Riedl A, Bannert N, Wisser AS, Wie-denmann B, Klapp BF, Tache Y, Kobelt P: Desacyl ghrelin inhibits the orexigenic effect of peripherally injected ghrelin in rats. Peptides 2008; 29:2159-2168.
14. Zhang W, Chai B, Li JY, Wang H, Mulholland MW: Effect of des-acyl ghrelin on adiposity and glucose metabolism. Endocrinology 2008; 149:4710-4716.
15. Martens K, Bottelbergs A, Baes M: Ectopic recombination in the central and peripheral nervous system by aP2/FABP4-Cre mice: implications for metabolism research. FEBS Lett 2010; 584:1054-1058.
16. Longo KA, Charoenthongtrakul S, Giuliana DJ, Gov-ek EK, McDonagh T, Qi Y, DiStefano PS, Geddes BJ: Improved insulin sensitivity and metabolic flexibility in ghrelin receptor knockout mice. Regul Pept 2008; 150:55-61.
17. Nonogaki K, Nozue K, Oka Y: Hyperphagia alters expression of hypothalamic 5-HT2C and 5-HT1B receptor genes and plasma des-acyl ghrelin levels in Ay mice. Endocrinology 2006; 147:5893-900.
18. Pacifico L, Poggiogalle E, Costantino F, Anania C, Ferraro F, Chiarelli F, Chiesa C: Acylated and non-acylated ghrelin levels and their associations with insulin resistance in obese and normal weight children with metabolic syndrome. Eur J Endocrinol 2009; 161:861-870.
19. St-Pierre DH, Karelis AD, Coderre L, Malita F, Fontaine J, Mignault D, Brochu M, Bastard JP, Cianflone K, Doucet E, Imbeault P, Rabasa-Lhoret R: Association of acylated and nonacylated ghrelin with insulin sensitivity in overweight and obese postmenopausal women. J Clin Endocrinol Metab 2007; 92:264-269.
20. Barazzoni R, Zanetti M, Ferreira C, Vinci P, Pirulli A, Mucci M, Dore F, Fonda M, Ciocchi B, Cattin L, Guarnieri G: Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome. J Clin Endocrinol Metab 2007; 92: 3935-3940.
21. Prodam F, Bellone S, Grugni G, Crino A, Ragusa L, Franzese A, Di Battista E, Corrias A, Walker G, Rapa A, Aimaretti G, Bona G: Influence of age, gender, and glucose tolerance on fasting and fed acylated ghrelin in Prader-Willi syndrome. Clin Nutr 2009; 28:94-99.
22. Yi CX, Heppner K, Tschop MH: Ghrelin in eating disorders. Mol Cell Endocrinol 2011; 340:29-34.
23. Miegueu P, St Pierre D, Broglio F, Cianflone K: Effect of desacyl ghrelin, obestatin and related peptides on triglyceride storage, metabolism and GHSR signaling in 3T3-L1 adipocytes. J Cell Biochem 2011; 112: 704-714.
24. Mackelvie KJ, Meneilly GS, Elahi D, Wong AC, Barr SI, Chanoine JP: Regulation of appetite in lean and obese adolescents after exercise: role of acylated and desacyl ghrelin. J Clin Endocrinol Metab 2007; 92: 648-654.
25. Kim HJ, Lee S, Kim TW, Kim HH, Jeon TY, Yoon YS, Oh SW, Kwak H, Lee JG: Effects of exercise-induced weight loss on acylated and unacylated ghrelin in overweight children. Clin Endocrinol (Oxf) 2008; 68:416-422.
26. Barnett BP, Hwang Y, Taylor MS, Kirchner H, Pfluger PT, Bernard V, Lin YY, Bowers EM, Mukher-jee C, Song WJ, Longo PA, Leahy DJ, Hussain MA, Tschop MH, Boeke JD, Cole PA: Glucose and weight control in mice with a designed ghrelin O-acyltrans-ferase inhibitor. Science 2010; 330:1689-1692.
27. Maletinska L, Matyskova R, Maixnerova J, Sykora D, Pychova M, Spolcova A, Blechova M, Drapalova J, Lacinova Z, Haluzik M, Zelezna B: The Peptidic GHS-R antagonist [ D-Lys(3)]GHRP-6 markedly improves adiposity and related metabolic abnormalities in a mouse model of postmenopausal obesity. Mol Cell Endocrinol 2011; 343:55-62.
28. Cederberg H, Rajala U, Koivisto VM, Jokelainen J, Surcel HM, Keinanen-Kiukaanniemi S, Laakso M: Unacylated ghrelin is associated with changes in body composition and body fat distribution during long-term exercise intervention. Eur J Endocrinol. 2011; 165:243-248.
29. Benso A, St-Pierre D, Prodam F, Gramaglia E, Granata R, Van der Lely AJ, Ghigo E, Broglio F: Metabolic effects of overnight continuous infusion of unacylated ghrelin in humans. Eur J Endocrinol 2012; 166:911-916.
30. Gauna C, van de ZB, van KA, Themmen AP, van der Lely AJ, Delhanty PJ: Unacylated ghrelin is not a functional antagonist but a full agonist of the type 1a growth hormone secretagogue receptor (GHS-R). Mol Cell Endocrinol 2007; 274:30-34.
31. Gauna C, Delhanty PJ, van Aken MO, Janssen JA, Themmen AP, Hofland LJ, Culler M, Broglio F, Ghigo E, van der Lely AJ: Unacylated ghrelin is active on the INS-1E rat insulinoma cell line independently of the growth hormone secretagogue receptor type 1a and the corticotropin releasing factor 2 receptor. Mol Cell Endocrinol 2006; 251:103-111.
32. Halem HA, Taylor JE, Dong JZ, Shen Y, Datta R, Abizaid A, Diano S, Horvath TL, Culler MD: A novel growth hormone secretagogue-1a receptor antagonist that blocks ghrelin-induced growth hormone secretion but induces increased body weight gain. Neuroendocrinology 2005; 81:339-349.